GECAMed, First Luxembourgish Software to Obtain IHE Conformity

GECAMedGECAMed, the medical office management software, developed by the Luxembourg Institute of Science and Technology (LIST) and widely used by Luxembourgish healthcare professionals, has successfully passed IHE profile conformance testing. The interoperability of GECAMed with other solutions available for professionals in the healthcare sector is therefore clearly demonstrated, a first for a Luxembourgish product and moreover for an open source solution.

At the end of April 2015, researchers from the Luxembourg Institute of Science and Technology (LIST) participated in the IHE-Europe Connectathon, an annual connectivity test marathon organised in Luxembourg by IHE-Europe in partnership with the national eSanté Agency. IHE-Europe is the European section of Integrating the Healthcare Enterprise (IHE), an international initiative bringing together professionals from the healthcare and industry sectors, including LIST, to improve information exchange between software systems in this field. The IHE initiative defines integration profiles in order to achieve a high interoperability rate between the systems available to healthcare professionals. The validity of their implementation is tested every year in the context of the Connectathon, where industry professionals meet and connect their applications by using the IHE profiles for designing virtual hospital information systems within a variety of fields, including radiology, cardiology, patient-devices, IT infrastructure, etc.

For the latter, LIST submitted its GECAMed medical office management software for an intensive week of conformance testing, which it successfully passed. GECAMed has thus become not only the first system in Luxembourg to be certified but also the first open-source medical office management system to pass this test with flying colours. This event marks real recognition for the software, since the proven IHE conformity certifies that GECAMed meets all of the strict interoperability criteria regarding security and data sharing at a high international standard.

Towards the integration of GECAMed in the national eHealth platform
GECAMed is a secure open source platform developed by LIST researchers in partnership with doctors in order to manage and use medical data. First launched in 2005 with the support of the Ministry of Health, it has since been constantly adapted and improved in order to meet the needs of professionals in the healthcare sector.

Researchers are currently working towards its technical integration into the national eHealth platform as part of the GECAMed eSanté project co-funded by the eHealth Agency and IDO IN. They therefore designed a new version which integrates patient data from shared medical records (Dossier de Soins Partagé - DSP) with GECAMed data in a user-friendly and transparent way, while complying with the data security and protection guidelines established by the eHealth Agency. Thanks to developments achieved within this project, healthcare professionals will no longer be forced to use the web interface of the eHealth platform. They will have direct access to all documents from their own patient record into which they will also be able to directly integrate documents from the DSP. Local documents and documents from the eHealth platform will therefore be able to be managed very quickly and easily with GECAMed.

For further information, please visit:
http://www.gecamed.lu

About Luxembourg Institute of Science and Technology (LIST)
The Luxembourg Institute of Science and Technology (LIST) is an RTO (Research and Technology Organisation) active in the fields of materials, environment, and IT. Our mission is twofold:

  • contributing to Luxembourg's reputation through our participation in several targeted research areas among the best RTOs,
  • significantly participating in the country's socio-economic development.

To this end, we participate in several national and European competitive research programmes. We disseminate our results through scientific publications in internationally renowned journals, results that we protect by filing patents and that we transfer to key players in the private or public sector.

Thanks to our activities in applied research and technology transfer, we support companies in their innovation projects. The objective is to enable them to enhance their competitiveness in regional, national, and international markets.

Furthermore, we also contribute to the setting up of new companies in Luxembourg through the development of innovative technology and expertise.

Lastly, we offer our scientific support to national policy making in our research areas in order to forecast and support societal changes.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...